MedinCell
Logotype for MedinCell S.A.

MedinCell (MEDCL) investor relations material

MedinCell H2 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for MedinCell S.A.
H2 25/26 earnings summary16 Jun, 2026

Executive summary

  • Strong royalty growth from UZEDY® (risperidone LAI), with net sales by Teva reaching $250 million and royalties up 54% in USD (42% in EUR) year-over-year, supported by FDA label expansion into bipolar I disorder.

  • Advanced three growth engines: UZEDY®, olanzapine LAI (anticipated US launch Q4 2026), and innovation partnerships including AbbVie, with a pipeline of 15 active programs.

  • Transitioned toward a model with multiple commercialized products, recurring royalty revenues, and disciplined investment in pipeline expansion.

  • Strengthened technology platform and governance, with new independent board members and continued innovation in proprietary drug delivery technologies.

  • Continued investment phase with increased operating expenses to support future growth and innovation platform expansion.

Financial highlights

  • Total income for the period was €24.3 million, down from €27.7 million year-over-year due to absence of milestone payments.

  • UZEDY® royalties increased to $10.9 million (€9.3 million), up 54% in USD and 42% in EUR year-over-year.

  • Operating expenses rose to €45.0 million from €38.5 million, mainly due to increased R&D and business development investments.

  • Net loss totaled €31.3 million, compared to €18.4 million loss in the prior year, including a €5.4 million non-cash impact from EIB warrants.

  • Liquidity position at €84.8 million, bolstered by a €48.2 million capital raise in March 2026.

Outlook and guidance

  • UZEDY® expected to approach $300 million in sales for 2026, on track for blockbuster status by early 2030s.

  • Olanzapine LAI anticipated to launch in Q4 2026 in the U.S., with meaningful revenues expected from H2 2027, pending regulatory approval.

  • AbbVie program to enter clinical stage in 2027, with up to $315 million in milestones per program.

  • Additional partnerships and licensing deals anticipated to drive future growth.

  • Continued focus on expanding the product pipeline and recurring royalty streams to drive sustainable profitability.

Olanzapine LAI safety vs existing formulations
Technical hurdles for BEPO platform expansion
Commercial segmentation of UZEDY and olanzapine
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next MedinCell earnings date

Logotype for MedinCell S.A.
H1 26/278 Dec, 2026
MedinCell
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next MedinCell earnings date

Logotype for MedinCell S.A.
H1 26/278 Dec, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Explore our global coverage